Literature DB >> 26767004

Video-assisted thoracoscopic lobectomy with a single utility port is feasible in the treatment of elderly patients with peripheral lung cancer.

Chang Li1, Chun Xu2, Haitao Ma2, Bin Ni2, Jun Chen2, Tengfei Chen2, Hongtao Zhang3, Jun Zhao1.   

Abstract

BACKGROUND: Video-assisted thoracoscopic (VATS) lobectomy with a single utility port has emerged as a new technology in recent years. The aim of this study is to review the technology in the treatment of elderly patients with peripheral lung cancer.
METHODS: We retrospectively analyzed the clinical data of 21 elderly patients with peripheral lung cancer who underwent single utility port VATS lobectomy from February 2011 to February 2013 in the First Affiliated Hospital of Soochow University (VATS group). The clinical outcomes and postoperative complications were then compared to data from 32 elderly patients who underwent lobectomy by thoracotomy (TL group).
RESULTS: No mortality occurred during the postoperative period in either group. There was no statistical difference in surgery duration, the quantity of lymph node dissection or intraoperative blood loss between the VATS and TL groups. However, significant differences existed in the postoperative hospital stay (6.19 ± 1.69 days vs. 8.22 ± 2.55 days), time to first activity out of bed (20.57 ± 7.72 hours vs. 26.81 ± 9.27 hours), chest drainage duration (4.24 ± 1.04 days vs. 5.22 ± 1.29 days), and total postoperative drainage volume (642.86 ± 158.18 mL vs. 787.81 ± 211.55 mL) between the VATS and TL groups (P <0.05). The percentage of patients with no complications in the VATS group (85.71%) is significantly higher when compared with the TL group (56.25%, P <0.05).
CONCLUSION: VATS lobectomy with a single utility port is a safe and feasible surgical procedure for selected elderly patients with peripheral lung cancer.

Entities:  

Keywords:  Aged; lobectomy; lung neoplasms; single utility port

Year:  2014        PMID: 26767004      PMCID: PMC4704302          DOI: 10.1111/1759-7714.12081

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


  35 in total

1.  Incidence of chest wall paresthesia after video-assisted thoracic surgery for primary spontaneous pneumothorax.

Authors:  Alan D L Sihoe; Sylvia S W Au; Mabel L Cheung; Ivan K L Chow; Ka Man Chu; Chun Yat Law; Maxim Wan; Anthony P C Yim
Journal:  Eur J Cardiothorac Surg       Date:  2004-06       Impact factor: 4.191

Review 2.  Surgery for nonsmall cell lung cancer.

Authors:  Loïc Lang-Lazdunski
Journal:  Eur Respir Rev       Date:  2013-09-01

Review 3.  Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.

Authors:  Tokujiro Yano; Akira Haro; Yasunori Shikada; Riichiroh Maruyama; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2011-05-13       Impact factor: 3.402

4.  Quantitative sensory testing of persistent pain after video-assisted thoracic surgery lobectomy.

Authors:  K Wildgaard; T K Ringsted; H J Hansen; R H Petersen; M U Werner; H Kehlet
Journal:  Br J Anaesth       Date:  2011-10-05       Impact factor: 9.166

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Smoking, occupational risk factors, and bronchial tumor location: a possible impact for lung cancer computed tomography scan screening.

Authors:  Maria Gonzalez; Jean-Michel Vignaud; Christelle Clement-Duchene; Amandine Luc; Pascal Wild; Odile Bertrand; Luc Thiberville; Yves Martinet; Jacques Benichou; Christophe Paris
Journal:  J Thorac Oncol       Date:  2012-01       Impact factor: 15.609

7.  Comparison of costs for video-assisted thoracic surgery lobectomy and open lobectomy for non-small cell lung cancer.

Authors:  Sukki Cho; Young Woo Do; Eung Bae Lee
Journal:  Surg Endosc       Date:  2010-09-11       Impact factor: 4.584

8.  Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer.

Authors:  Robert E Merritt; Chuong D Hoang; Joseph B Shrager
Journal:  Ann Thorac Surg       Date:  2013-07-31       Impact factor: 4.330

9.  Morbidity risks among older adults with pre-existing age-related diseases.

Authors:  Igor Akushevich; Julia Kravchenko; Svetlana Ukraintseva; Konstantin Arbeev; Alexander Kulminski; Anatoliy I Yashin
Journal:  Exp Gerontol       Date:  2013-09-21       Impact factor: 4.032

Review 10.  Management of non-small-cell lung cancer: recent developments.

Authors:  Martin Reck; David F Heigener; Tony Mok; Jean-Charles Soria; Klaus F Rabe
Journal:  Lancet       Date:  2013-08-24       Impact factor: 79.321

View more
  2 in total

Review 1.  Thoracotomy is better than thoracoscopic lobectomy in the lymph node dissection of lung cancer: a systematic review and meta-analysis.

Authors:  Wenxiong Zhang; Yiping Wei; Han Jiang; Jianjun Xu; Dongliang Yu
Journal:  World J Surg Oncol       Date:  2016-11-17       Impact factor: 2.754

2.  Uniportal thoracoscopic pulmonary lobectomy in the treatment of Lung Cancer.

Authors:  Jinying Zhang; Haixia Zhao; Lingmei Lv; Jiang Yuan; Yuzhen Sun
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.